FDA Inspection
Orthobone, Inc.Orthobone, Inc. – FDA Inspection, Mar 2, 2012
Record Details
This FDA Inspection record concerns Orthobone, Inc., with an inspection on March 2, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Orthobone, Inc.
- Inspection Date
- March 2, 2012
- Product Type
- Biologics
View Company Profile
ID · c672cd56-d06e-4975-8822-ed37ec63d8a5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 770808
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
3- 21 CFR 1271.265(d)Shipping conditions appropriate
- 21 CFR 1271.170(c)Trained or re-trained as necessary
- 21 CFR 1271.265(f)Return to inventory--procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Orthobone, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 18, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 15, 2020 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 16, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 4, 2016 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Orthobone, Inc.
- FDA Inspection 1242170 - 2024-06-18
- FDA Inspection 1115375 - 2020-01-15
- FDA Inspection 1065410 - 2018-08-16
- FDA Inspection 970058 - 2016-05-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.